Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Beijing Tong Ren Tang Chinese Medicine Co ( (HK:3613) ) just unveiled an announcement.
Beijing Tong Ren Tang Chinese Medicine Company Limited announced the unaudited financial results of its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., for the nine months ending September 30, 2025. This disclosure is part of regulatory requirements and reflects the company’s transparency in financial reporting. The announcement may impact investor decisions and market perception, given the company’s significant role in the traditional Chinese medicine sector.
The most recent analyst rating on (HK:3613) stock is a Hold with a HK$9.50 price target. To see the full list of analyst forecasts on Beijing Tong Ren Tang Chinese Medicine Co stock, see the HK:3613 Stock Forecast page.
More about Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Company Limited operates in the traditional Chinese medicine industry, focusing on the production and distribution of Chinese medicinal products. The company is primarily involved in the development and sale of herbal medicines and health products, with a significant market presence in Hong Kong and other regions.
Average Trading Volume: 1,231,437
Technical Sentiment Signal: Sell
Current Market Cap: HK$7.29B
For an in-depth examination of 3613 stock, go to TipRanks’ Overview page.